Cargando…
1640. Toward New Anti-Biofilm Therapies: High Mobility Group Box 1 (HMGB1) Protein and Its Structural Variants Can Be Used to Disrupt Bacterial Biofilms (BBs)
BACKGROUND: BB-related infections are a major public health problem, as they are notoriously refractory to current treatments. One of the defining characteristics of BBs is the extracellular polymeric substance (EPS). Extracellular DNA and the bacterial DNABII family of proteins are key components o...
Autores principales: | Katragkou, Aspasia, Warren, Lauren, Buzzo, John, Goodman, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252871/ http://dx.doi.org/10.1093/ofid/ofy209.110 |
Ejemplares similares
-
Bacterial Biofilms Utilize an Underlying Extracellular DNA Matrix Structure That Can Be Targeted for Biofilm Resolution
por: Goodman, Steven D., et al.
Publicado: (2022) -
High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005) -
The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014) -
Biofilm dispersion: The key to biofilm eradication or opening Pandora’s box?
por: Wille, Jasper, et al.
Publicado: (2020) -
PYED-1 Inhibits Biofilm Formation and Disrupts the Preformed Biofilm of Staphylococcus aureus
por: Vollaro, Adriana, et al.
Publicado: (2020)